161 related articles for article (PubMed ID: 24452068)
1. Serum concentrations of hydroxybupropion for dose optimization of depressed patients treated with bupropion.
Laib AK; Brünen S; Pfeifer P; Vincent P; Hiemke C
Ther Drug Monit; 2014 Aug; 36(4):473-9. PubMed ID: 24452068
[TBL] [Abstract][Full Text] [Related]
2. Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations.
Jefferson JW; Pradko JF; Muir KT
Clin Ther; 2005 Nov; 27(11):1685-95. PubMed ID: 16368442
[TBL] [Abstract][Full Text] [Related]
3. HPLC assay for bupropion and its major metabolites in human plasma.
Loboz KK; Gross AS; Ray J; McLachlan AJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 823(2):115-21. PubMed ID: 16011913
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective bupropion hydroxylation as an in vivo phenotypic probe for cytochrome P4502B6 (CYP2B6) activity.
Kharasch ED; Mitchell D; Coles R
J Clin Pharmacol; 2008 Apr; 48(4):464-74. PubMed ID: 18287571
[TBL] [Abstract][Full Text] [Related]
5. CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion.
Zhu AZ; Cox LS; Nollen N; Faseru B; Okuyemi KS; Ahluwalia JS; Benowitz NL; Tyndale RF
Clin Pharmacol Ther; 2012 Dec; 92(6):771-7. PubMed ID: 23149928
[TBL] [Abstract][Full Text] [Related]
6. Determination of bupropion and its main metabolite in rat plasma by LC-MS and its application to pharmacokinetics.
Hu L; Wang Z; Xu R; Ma J; Wang X; Zhang X
Pharmazie; 2011 Dec; 66(12):924-8. PubMed ID: 22312695
[TBL] [Abstract][Full Text] [Related]
7. Effect of CYP2B6*6 on Steady-State Serum Concentrations of Bupropion and Hydroxybupropion in Psychiatric Patients: A Study Based on Therapeutic Drug Monitoring Data.
Høiseth G; Haslemo T; Uthus LH; Molden E
Ther Drug Monit; 2015 Oct; 37(5):589-93. PubMed ID: 25565674
[TBL] [Abstract][Full Text] [Related]
8. Acute antidepressant response and plasma levels of bupropion and metabolites in a pediatric-aged sample: an exploratory study.
Daviss WB; Perel JM; Brent DA; Axelson DA; Rudolph GR; Gilchrist R; Nuss S; Birmaher B
Ther Drug Monit; 2006 Apr; 28(2):190-8. PubMed ID: 16628130
[TBL] [Abstract][Full Text] [Related]
9. Effect of St. John's wort supplementation on the pharmacokinetics of bupropion in healthy male Chinese volunteers.
Lei HP; Yu XY; Xie HT; Li HH; Fan L; Dai LL; Chen Y; Zhou HH
Xenobiotica; 2010 Apr; 40(4):275-81. PubMed ID: 20102294
[TBL] [Abstract][Full Text] [Related]
10. Effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion and its active metabolite, 4-hydroxybupropion, in healthy subjects.
Kim H; Bae SK; Park SJ; Shim EJ; Kim HS; Shon JH; Liu KH; Shin JG
Br J Clin Pharmacol; 2010 Jul; 70(1):126-31. PubMed ID: 20642555
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective analysis of bupropion and hydroxybupropion in human plasma and urine by LC/MS/MS.
Coles R; Kharasch ED
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 857(1):67-75. PubMed ID: 17656162
[TBL] [Abstract][Full Text] [Related]
12. Determination of hydroxybupropion in human serum for routine therapeutic drug monitoring in psychiatry: A tool for dose-individualization in treatment with bupropion.
Scherf-Clavel M; Wahl O; Menke A; Unterecker S
Biomed Chromatogr; 2019 Oct; 33(10):e4609. PubMed ID: 31150132
[TBL] [Abstract][Full Text] [Related]
13. Duloxetine serum concentrations and clinical effects. Data from a therapeutic drug monitoring (TDM) survey.
Waldschmitt C; Vogel F; Pfuhlmann B; Hiemke C
Pharmacopsychiatry; 2009 Sep; 42(5):189-93. PubMed ID: 19724981
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective analysis of hydroxybupropion and application to drug interaction studies.
Xu H; Loboz KK; Gross AS; McLachlan AJ
Chirality; 2007 Mar; 19(3):163-70. PubMed ID: 17167747
[TBL] [Abstract][Full Text] [Related]
15. Lopinavir/ritonavir reduces bupropion plasma concentrations in healthy subjects.
Hogeland GW; Swindells S; McNabb JC; Kashuba AD; Yee GC; Lindley CM
Clin Pharmacol Ther; 2007 Jan; 81(1):69-75. PubMed ID: 17186001
[TBL] [Abstract][Full Text] [Related]
16. Single-dose pharmacokinetics of bupropion in adolescents: effects of smoking status and gender.
Stewart JJ; Berkel HJ; Parish RC; Simar MR; Syed A; Bocchini JA; Wilson JT; Manno JE
J Clin Pharmacol; 2001 Jul; 41(7):770-8. PubMed ID: 11452710
[TBL] [Abstract][Full Text] [Related]
17. Steady-state clinical pharmacokinetics of bupropion extended-release in youths.
Daviss WB; Perel JM; Birmaher B; Rudolph GR; Melhem I; Axelson DA; Brent DA
J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1503-9. PubMed ID: 17135996
[TBL] [Abstract][Full Text] [Related]
18. Development, validation and application of a comprehensive stereoselective LC/MS-MS assay for bupropion and oxidative, reductive, and glucuronide metabolites in human urine.
Teitelbaum AM; Flaker AM; Kharasch ED
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():239-53. PubMed ID: 27318149
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of Bupropion and Its Pharmacologically Active Metabolites in Pregnancy.
Fokina VM; Xu M; Rytting E; Abdel-Rahman SZ; West H; Oncken C; Clark SM; Ahmed MS; Hankins GD; Nanovskaya TN
Drug Metab Dispos; 2016 Nov; 44(11):1832-1838. PubMed ID: 27528039
[TBL] [Abstract][Full Text] [Related]
20. Subtherapeutic bupropion and hydroxybupropion serum concentrations in a patient with CYP2C19*1/*17 genotype suggesting a rapid metabolizer status.
Gaebler AJ; Schneider KL; Stingl JC; Paulzen M
Pharmacogenomics J; 2020 Dec; 20(6):840-844. PubMed ID: 32475982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
